เกี่ยวกับตอนนี้
Sepsis remains one of medicine's most difficult diagnostic challenges, where every hour can impact patient outcomes. In this episode of Innovate & Elevate, Sharon Kedar sits down with Dr. Tim Sweeney, Co-Founder and CEO of Inflammatix, to explore how advances in artificial intelligence, host-response diagnostics, and precision medicine could transform the way clinicians detect infection and critical illness. Dr. Sweeney shares the personal experience that launched his two-decade mission to improve sepsis care, explains why traditional diagnostic approaches often fall short, and discusses how Inflammatix's TriVerity™ platform is helping physicians identify the right patients for the right treatment at the right time.
This Episode Is For You If:- You want to understand why sepsis remains one of healthcare's most challenging diagnoses.
- You're interested in how artificial intelligence is being applied to real-world clinical decision-making.
- You want to learn how innovation can improve outcomes for critically ill patients.
Connect with Dr. Tim Sweeney:
- LinkedIn: https://linkedin.com/in/tim-sweeney-a6589594/
- X: https://x.com/timsweeney83
- Inflammatix: https://inflammatix.com
Connect with Sharon:
- Connect with Sharon on LinkedIn: https://www.linkedin.com/in/sharonkedar/
- Learn more about Innovate and Elevate: https:// innovateandelevatepodcast.com
- Join the newsletter to receive the latest episodes in your inbox: https://innovateandelevatepodcast.com/email
The content shared in this episode is for informational purposes only and does not constitute medical, financial, or investment advice. Please seek guidance from your own qualified professionals before making decisions.
Timestamps(00:00) The Patient That Changed Everything
(01:57) Why Sepsis Is So Difficult to Solve
(03:10) What Sepsis Really Is
(05:59) Why Early Diagnosis Matters
(08:18) Introducing TriVerity
(12:17) A Life Saved by Earlier Detection
(17:10) The Science of Host Response
(19:07) How AI Interprets the Immune System
(25:22) The Future of Precision Critical Care
(31:28) Improving Care Beyond Saving Lives
About Our Guest: Tim Sweeney, MD, PhD, is co-founder and CEO of Inflammatix, a clinical-stage startup bringing precision medicine to hospital care. He led the company from its Stanford roots through product development, clinical validation, FDA clearance, and commercialization. His background spans clinical medicine (surgery), data science, and translational diagnostics, giving him a practical view of both clinical need and market adoption. Tim is named on more than a dozen patents, has published more than 100 manuscripts and abstracts, and has served as PI on multiple development contracts from DOD/DARPA, BARDA, and NIH. He lives with his wife and 3 boys in Northern California.
About Sharon: Sharon Kedar is a co-founder and partner at Northpond Ventures, a multi-billion-dollar science-driven venture capital firm. Sharon holds an MBA from Harvard Business School and is a CFA charter holder. She lives in the Washington, DC area with her husband, Greg, their three kids, and their dog Bo.
This podcast is produced by Brave Moon Podcasts.
